TTS Pharma Ltd

Executive Management Team

TTS Pharma is led by an experienced management team with pharmaceutical and public company expertise and a proven track record of innovative, and effective product development and supply chain management. 

Mr. Paul Atherton


Paul is the former CEO and CFO of Heritage Oil, which had a premium listing on the Main Board of the London Stock Exchange and was a member of the FTSE 250 until being acquired for US $1.6 billion in 2014. He has a corporate finance background with over 20 years’ experience in the international natural resource sectors and is a chartered accountant. Paul was appointed Chairman in 2019 following an equity investment.

Mr. Wilson Blaney BSc (Hons)

Director of Quality
As Director of Quality, Wilson has responsibility for ensuring our ‘quality ethos’ is embedded within the business culture at all levels. Standards and specifications of the products and production processes are integrated into upstream / downstream agreements with suppliers and clients within relevant regulatory requirements. Wilson was previously Head of Operations at an Imperial plc subsidiary (Nerudia – Next Generation Products) after a number of ‘Quality’ roles within the pharmaceutical sector incl. Sanofi Aventis, GSK, Boots, Genzyme, Novartis and IPSEN and is therefore familiar with a wide range of licensed products, processes and regulatory environments.

Mr. Robin Emerson

Director of Business Development &. Media Affairs
Robin founded Elite Growth & Jorja Botanicals, a family brand for family values. As a leading UK advocate for the expansion of medical cannabis in the UK, Robin’s campaigning was inspired by his experience with his own daughter, Jorja, whose intractable epilepsy has been successfully treated by medicinal cannabis for the past 3/4 years. Together their combined high profile facilitates our engagement across various media channels and the political spectrum as this market continues to evolve.